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---Synopsis--------------------
RADIOLOGY IN THE DIAGNOSIS OF CONGENITAL HEART 
DISEASE 
The majority of congenital malforma-
tions may be differentiated by study of 
information obtained on physical exami-
nation, electro-cardiograms, X-ray and a 
fluoroscopic examination. 
In a small percentage of cases, how-
ever, the more recent technique of angio-
cardiography and heart cathetrization are 
proving to be valuable in diagnosing some 
of the more difficult cases. 
Fluoroscopy has more advantages than 
X-ray in that it allows examination of 
the patient in numerous positions and 
brings to light any artefacts produced by 
moving the heart and shoulders. Barium 
swallows give an indication of the rela-
tionship of the esophagus and heart. 
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Various positions of examination gives 
different information about the heart and 
vessels: 
1-the antero-posterior position 'bows 
the size and shape of the heart and 
great vessels, 
2-the left anterior oblique positio.'l 
shows the relative size of the ven-
tricles, 
3-the course of the aorta and the size 
of the left auricle may be deter-
mined from the right anterior 
oblique position . 
The cardiac silhouette is considered to 
be of little help in the infant. 
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Office Procedure in the Diagnosis 
of Hem.atologic Disorders 
wr. BRUCE BARTON, M.D., F.R.C.P.(C). 
INTRODUCTION 
It is not generally appreciated that a practitioner, with a minimum of equip-
ment, some knowledge and a fair amount of patience can make in his office a 
reasonably neat diagnosis of a blood dyscrasia . The categorization of abnormalities 
of the peripheral blood is not strictly an exercise for a hospital laboratory, if a 
few inexpensive tools and a knowledge of how to use them are at hand. 
This article wi ll make no attempt to classify abnormalities of th e hemo-
poietic system. Rather, the purpose is to draw to the reader's attention some 
basic facts , the appreciation of which may contribute towards making the prac-
tice of medicine a little less hum-drum and perhaps a little more exciting. 
Furthermore, one may say that treatm ent can scarcely be rational wi thout a 
precise diagnosis. H ence the necessi ty for a definite diagnosis, if at all possible, 
is self-evident. Poly pharmacy as it stands today may seem superficially to have 
simplified these problems but it has, in fact, introduced many new ones, for with-
out any idea of the specificity of a response one may still be in doubt about the 
exact nature of the disease which he is trea ting. 
It is perhaps superfluous to mention 
the importance of an adequate history, 
but it is really a paramount essential. For 
example, if one is dealing with an anemia, 
he must know whether blood loss has 
been occurring ; whether the diet has been 
adequate; whether there may be asso-
ciated infection, neoplasm, liver or kid-
ney disease ; whether potentially harmful 
drugs have been ingested; whether a 
harmful exposure to chemicals may have 
occutred. 
Physical examination is equally im-
portant. One seeks especially for en-
larged lymph nodes, bone tenderness, 
petechiae, or any peculiar skin lesions, 
jaundice, enlargement of the liver and/or 
spleen, and, of course, any other palpable 
masses. The old dictum about the abso-
lute crime of not inserting a finger into 
the rectum may be mentioned here. 
Actually the diagnosis of an hemato-
logic disorder is most often , in the final 
analysis, a laboratory procedure. One can 
only make a presumptive diagnosis as a 
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rule, without laboratory aid. Herewith 
then, will be descr ibed office laboratory 
procedures which can be quite definite. 
( 1) Hemoglobin Estimation 
The methods which are used in the 
office of a busy practitioner must of 
necessity be simple and ideally not in-
volve the fl.c quisition of expensive ap-
paratus. Estimations of hemoglobin level 
done by the Tallqvist or Sahli method 
are in such a category, but the important 
feature to be remembered is that the range 
of accu racy may be as poor as -+- 15 to 
-1- 30%. Accordingly, a mild anemia 
(10.0 Gm.) may be read as 8.5 Gm. 
(a fairly severe anemia) or as 11.5 G.m. 
(a barely borderline anemia in the fe-
male) , using the Sahli method. If the 
Tallqvist method is used a mild anemia 
(10.0 Gm.) may be read as 13.0 Gm. 
(normal in the female) or as 7.0 Gm . (a 
severe anemia). Using the Spencer colori-
metri c method a greater range of accur-
acy (-+- 5 to -+- 10% ) rna y be obtained. 
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For the optimal accuracy photoelectric 
methods must be employed. This appar-
atus may be temperamental and is subject 
to error too, but a photoelectric machine 
will deliver with an accuracy of -t-1 to 
-+- 2o/o. The normal range of hemoglobin 
is 12- 16 Gm. in the female, and 14- 18 
Gm. in the male. This terminology is the 
accepted and certainly the logical one at 
the moment. Since the normal hemo-
globin has a range it seems quite un-
scientific to select one value as represent-
ing 100% . In other words, anything be-
tween 14 and 18 Gm. in the male is 100%. 
The reporting of hemoglobin in per-
centage, then, has little to recommend it, 
and one rarely sees this done now. 
(2) Red Cell Counts 
These are mentioned simply to condemn 
them. Such counts are most difficult to 
do with a reproducible accuracy. To per-
form a guite accurate count, two pipettes 
with balanced correction factors and two 
counting chambers must be used. If in-
accurate red cell counts ar·e used for the 
calculation of indices (e.g. color index), 
the error is compounded and the physi-
cian may be severely mislead, but there is, 
of course, a real place for accurate red 
cell counts on occasion. However, as an 
office procedure they have nothing to 
recommend them. 
(3) Hematocrit (volume of packed red 
cells) 
It is unlikely that an adequate centri-
fuge will be available in the office of a 
practicing physician for the performance 
of this test. The ordinary centrifuge 
whi ch is used for spinning urine must 
never be used . A speed of somewhere be-
tween 2500 and 3000 r.p.m. is necessary 
for maximum packing of the red cells in 
the Wintrobe hematocrit tube. These 
speeds cannot be obtained except with 
centrifuges which are built for the job. 
The reproducible accuracy with which 
hematocrits can be performed is greatly 
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in favor of the routine use of this test. 
In addition, one can examine the color of 
the plasma and make a rough estimate of 
the level of white blood cells and platelets. 
The normal range is 47.0 -+- 7.0% in the 
male and 42.0 -+- 5.0% in the female. 
( 4) White Cell Count 
A white cell count is simply done and 
can be done accurately if the minimum of 
skill and care are used. This should be 
looked upon as an essential part of a com-
plete examination. The 110rmal range is 5,000 
- 10,000 per m. mm. 
( 5) Examination of a Smear of Peri-
pheral Blood 
A drop of fresh blood (from the finger-
tip or ear lobe) evenly and thinly spread 
on a clean glass slide (or preferably on 
a clean cover glass) and well-stained, is 
without doubt the most important single 
test available for the assessment of the 
status of the cellular components of the 
blood. From it, one can gain information 
on the character of the red cells-whether 
they are normal in size and shape, whether 
their hemoglobin content is normal and 
whether immature forms are present. On 
this observation depends mainly the selec-
tion of the proper agent for treatment. 
If the red cells are small and pale, the 
anemia is likely due to chronic blood loss. 
Immediately, an explanation for this must 
be sought. Ferrous sulfate by mouth will 
usually be effective, unless the blood loss 
is very rapid or unless iron cannot be 
absorbed from the gastro-intestinal tract. 
(This latter situation is a rare one in-
deed.) If the red cells are large, the bone 
marrow must be examined, for one may 
be dealing with a liver principle defi-
ciency anemia, in which case, the marrow 
will be megaloblastic. If the red cells are 
normal in size and shape and anemia is 
actually present a search must be con-
ducted for such things as chronic infec-
tion, uremia, acute blood loss, neoplasm, 
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myxedema, etc. If immature forms are 
present, causes of rapid blood formation 
must be sought for . By immature red 
cells one means nucleated forms, stippled 
forms and large bluish-grey forms. These 
last named cells are called polychromato-
philic red cells and they are likely reti-
culocytes. In order to both identify these 
cells as reticulocytes and to count them, 
supravital stains may be used. This is not 
as a rule an office procedure, but it could 
be. The important thing to appreciate is 
that the routine smear would give one a 
lead toward further investigation which 
can then be ordered for a legitimate 
reason . 
Red cells which are small and lack the 
normal central zone of pallor are called 
spherocytes. The finding of many of 
these on smear may mean a hemolytic 
anemia of either the acquired or con-
genital type. In the latter type they are 
apt to be much more numerous. The 
recognition of such cells then leads one 
to rational additional investigation. 
As well, one may gain information on 
the leucocyte picture. A differential count 
of at least one hundred white blood cells 
will give the answer on ail abnormal 
preponderance of any of the particular 
types of leucocytes and, even ·more im-
portant, will give information on whether 
or not any immaturity of granulocytes is 
present. The presence of granulocytes 
younger than the band or stab form must 
never go unexplained. The differential 
then , when paired with the total white 
count, will be the deciding features, not 
only in making a diagnosis of leukemia 
but in categorizing it. 
Also from the smear of peripheral 
blood the adequacy of platelets may be 
appraised. If many platelets are seen, 
they can be said simply to be adequate 
numerically. If they occur in clumps, it 
is almost certain that their number is 
normal. Occasionally giant forms are 
seen. These are abnormal and may mean 
a functional inadequacy. Platelet counts 
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are difficult to do as an occasional pro-
cedure and are, of course, not to be recom-
mended as an office exercise. Clearly, if 
their numbers are adequate on the smear, 
a count is quite superfluous. 
( 6) Bleeding Time, Clotting Time, 
Capillary Fragility 
If the patient presents a problem in 
abnormal bleeding, in addition to the 
evaluation of platelets, the physician may 
perform three simple tests - bleeding 
time, clotting time and capillary fragility . 
These, along with their rationale, have 
been dealt with by Dr. Meltzer in a sep-
arate paper in this issue of the Journal. 
(7) Sedimentation Rate 
The sedimentation rate which is nor-
mally looked upon as an index of tissue 
injury is increased actually because of an 
elevation in plasma globulins and/or 
plasma fibrinogen. Hence, it may be 
applied to hematologic diseases which do 
have changes in serum proteins. Striking 
elevations of serum globulin are seen 
usually in multiple myeloma (not a rare 
disease if it is kept in mind!) and lesser 
increases may be seen in Hodgkin's Dis-
ease and lymphocytic leukemia. Anemia 
itself has some accelerating effect on the 
fall of red cells, but if the Westergren 
method (which is the common one) is 
used, one does not need to correct for 
the degree of anemia. If the Wintrobe 
tube is used (and this is extremely con-
venient if a hematocrit is also going to 
be performed) , correction curves have 
been developed to adjust for the degree 
of anemia. But it seems to be attempting 
to introduce quite a degree of accuracy 
into a crude test, and most authorities 
will not bother with correcting for 
anemia. At best, the erythrocyte sedimen-
tation rate is only a screening test and 
its non-specificity makes it of limited 
value indeed in assessing the hematologic 
status of the patient. 
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(8) Bone Marrow Aspiration 
The aspiration of bone marrow (fr~m 
the sternum, iliac crests or poster~or 
spinous processes) is clearly an offtee 
procedure from the. technical ~oint of 
view and it carries ltttle or no nsk. The 
most important part of this procedure, 
however, is the preparation of the smears 
and their interpretation. These latter ex-
ercises require some experience, so I am 
not in favor of bone marrow aspirations 
being done by practitioners who are not 
in a position to interpret what they see. 
Furthermore, some help may be gained 
from actually observing the events dur-
ing the aspiration; the ease with which 
the bone was penetrated; the occurrence 
of suction pain ; the presence of "chunks" 
of bone marrow in the aspirate. If the 
person who is asked to make a diagnosis 
has not performed the aspiration, I think 
his position is a little more difficult: In 
addition, it should be clearly appreCiated 
that an appraisal of bone marrow aspirate 
is in no way a substitute for meticulous 
scanning of a film of peripheral blood. 
These examinations are simply comple-
mentary. I know of no contra-indications 
to bone marrow aspiration. One often 
hears that this procedure must not be 
done in the face of a bleeding tendency. 
There is no added risk in a patient who 
is bleeding, for most any bleeding from 
a hole created by a # 18 needle can be 




In conclusion it can be said that in 
the past fifteen ~ears a consideraple body 
of information has been accumulated re-
lati.ng to the blood dyscrasias. The utiliza-
tion· of these facts has removed therapy 
from the metaphysical sphere and placed 
it on a firm factual foundation. Not all 
blood dyscrasias are amenable to specific 
therapy for, very often, their etiology is 
unknown; hence no specific therapy .is 
available. Here such supportive measures 
as blood transfusion may be quite justi-
fied ·and, indeed, may be the only thera-
peutic agent; but when a dyscrasia can. ~e 
accurately categorized and a speof~c 
agent is available· fQr its treatment,. thts 
agent should be used, and preferably used 
alone. The need for precise diagnosis is 
surely obvious and it seems to me .that 
the practicing physician should be tn a 
position to make such a diagnosis. At 
this point it might be justifiable to make 
a plea for diagnosis before any therapy 
is given, for often times after some treat-
ment has been administered, even in small 
amounts, a precise diagnosis is extremely 
difficult or impossible. 
With the above laboratory procedures 
one can do a great deal toward making 
a diagnosis of an abnormality of the 
peripheral blood. The practicing physi-
cian will get a greater thrill out of his 
labors and the patient will certainly bene-
fit greatly, if the above-listed examina-
tion can be carried out and properly 
interpreted. 
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Leuketnia 
Gerald T. Cook, Meds '56 
INTRODUCTION 
The most important single step in the diagnosis of leukemia is the micro-
scopic examination of the stained blood film. The importance of this simple 
routine laboratory procedure cannot be stressed too strongly . However, many of 
these patients will be seen at a time when the hematologic findings do not give 
an immediate and effortless diagnosis. It should be emphasized, therefore, that 
these diseases are to be known by their entire natural history rather than by the 
few facts concerning their clinical pathology. 
Definition 
Leukerpia is a disease of unknown 
etiology, which follows a progressive 
course that is individually variable but 
always fatal. 
The acute and chronic forms of leu-
kemia are distinguishable primarily by 
their duration and the degree of im-
maturity of the predominating cells, the 
acute form having the more rapid course 
with its cells being the more immature. 
The leukemias are most conveniently 
classified according to the predominating 
types of cells. 
I. Chronic leukemia · 
a. Myelocytic 
b. Lymphocyti.c 




The Nature of Leukemia 
Leukemia is a disorderly, nonfunction-
ing overgrowth of myeloid or lymphoid 
cells, that is invariably fatal, and in these 
respects it resembles a malignant neo-
plasm. 
A minority opinion is that it belongs 
to the dim borderl-ine between inflamma-
tion and neoplasm. 
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Age and Sex Incidence 
The acute and chronic forms of leu-
kemia may occur in either sex at any 







under 5 years 
25 - 45 years 







: : 3/1 
"M/F-Male/Female Ratio 
Pathology 
The essential feature of leukemia is a 
neoplastic proliferation of leukoblastic 
tissue resulting in a great increase in the 
white cells of the blood and cellular in-
filtration of organs. Occasionally, there 
is a proliferation of white cells in the 
tissue but they fail to appear in the blood 
stream, a condition called "aleukemic 
leukemia". 
In chronic myelocytic leukemia there 
is a myeloid hyperplasia which largely 
crowds out the erythroblastic tissue. The 
spleen becomes enormously enlarged and 
firm, and may fill the entire abdomen . 
The liver is moderately enlarged; lymph 
nodes are usually normal in size. 
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In chronic lymphocytic leukemia the 
lymph nodes all over the body are en-
larged and their normal microscopic archi-
tecture is replaced by a diffuse mass of 
lymphoid cells. Other lymphoid tissue is 
similarly affected. The spleen is usually 
moderately enlarged. The hyperplastic 
bone marrow is composed largely of lym-
phoid cells. 
In the acute forms, the infiltrating cells 
are "blast" forms, but otherwise the in-
filtration in various tissues throughout 
the body is similar to that observed in the 
chronic leukemias. In addition, there is 





The onset is insidious. Frequently the 
initial complaints are weakness, pallor, 
palpitation and dyspnea, which are at-
tributable to the slowly advancing anemia. 
There may be a fullness and dragging sen-
sation in the abdomen due to the great 
splenic enlargement. Fever, of intermit-
tent or remittent type, may be an early 
symptom. During acute exacerbations, 
and as a late feature, hemorrhages may 
occur under the skin, from the uterus, 
kidneys, bowels, or into the retina or 
middle ear. 
These symptoms . become more pro-
nounced as the disease progresses. 
Physical Examination 
The general appearance of the patient 
varies widely depending upon the severity 
of anemia which is present. 
1. Spleen is characteristically much en-
larged, extending across the midline 
and reaching below the umbilicus. 
2. Liver is usually palpable, and may 
become enormous. 
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3. Lymph nodes may occasionally be 
slightly enlarged, but remain dis-
crete. 
4. There may be purpuric hemorrhages 
under the skin. 
5. As leukemic infiltrations may pres-
ent in almost any tissue of the body, 
the pos5ible complications are many; 
for example: 
i) retinal hemorrhages and leu-
kemic infiltrations. 
ii) bluish grey, elevated nodules 
in the skin. 
iii) destruction of bone. 
iv) deafness by hemorrhage or leu-
kemic infiltration in the inner 
or middle ears. 
v) hemorrhages or tumor-like in-
filtrations in the central nerv-
ous system. 
vi) hematuria. 
vii) gastrointestinal tract hemor-
rhages. 
Blood Examination 
1. R.B.C. : There IS a moderate but 
slowly increasing anemia of normo-
cytic and normochromic type; nu-
cleated red cells may be found. 
2. W .B.C.: Total count is 100,000 to 
500,000 per cubic millimeter, or 
more. The myelocyte is the pre-
dominant cell, but more primitive 
forms are seen in the terminal stages 
or in the blast crisis of leukemia. 
3. Platelets: Most frequently there is 
a slight increase in the blood plate-
lets, or in some instances the num-
bers may be reduced to a marked 
degree. 
. If it is remembered that the white cell 
count, the red cell count, and platelet 
count may each approach · 1,000,000, some 
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of the principal features of the blood pic-
ture may be recalled. 
Prognosis 
Spontaneous rem1ss1ons lasting from 
months to years, have been reported, but 
all cases are invariably fatal. About 50% 
of chronic myelocytic leukemia patients 
die in an acute phase. The mean survival 
time is generally reported to be between 
two and three years from the time of 
diagnosis. 
The terminal stage is indicated by: 
i) increased myeloblasts in peri-
pheral blood, 
ii) marked anemia, 
iii) hemorrhages, 





The onset is insidious. The clinical 
manifestations of anemia-pallor, weak-
ness, fatigue, dyspnea and palpitations-
may be the presenting symptoms. Fre-
quently the patient observes a painless, 
nontender lymph node in the neck, axilla 
or groin. Less frequently, itchy red skin 
caused by leukemic infiltration, or a hem-
orrhagic tendency may be the presenting 
complaint. 
Physical Examination 
Again, the general appearance of the 
patient depends upon the degree of anemia 
which is present. 
1. The lymph nodes of cervical, axil-
lary and inguinal regions are most 
frequently enlarged. They are firm, 
rubbery, discrete and painless. Some 
nodes may attain the size of a hen's 
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egg, and it is not uncommon to have 
them spontaneously diminish in size. 
The condition of the superficial 
lymph nodes is not always a reliable 
indication as to the presence or ab-
sence of general lymphoiJ hyper-
plasia, for the deep nodes ( abdom-
inal and mediastinal) may be greatly 
enlarged though the superficial ones 
are barely palpable. 
2. The firm non-tender edge of the 
spleen is most often palpable 7 to 
8 em. below the left costal margin, 
but never is a huge size attained. 
3. The liver is usually moderately 
enlarged. 
Blood Examination 
1. R.B.C.: Anemia is not nearly as 
marked as in chronic myelocytic 
leukemia. But as the disease pro-
gresses, a normocytic, normochromic 
anemia develops and becomes more 
severe. 
2. W.B.C. : Only the lymphoid cells 
are increased, and may form as 
much as 90% of the average total 
count of 50,000 to 100,000. 
3. Platelets : The platelet count is char-
acteristically moderately decreased, 
but occasionally there is a great fall 
or complete disappearance of plate-
lets resulting in bleeding. 
PROGNOSIS 
The prognosis is better than in chronic 
myelocytic leukemia. The average length 
of life in patients with chronic lympho-
cytic leukemia is usually given as 3.5 
years from the onset of symptoms. Some 
live for 5 or 10 years and undoubtedly 
a small percentage go into spontaneous 
remission for several months or years, but 
eventually the terminal stage of the dis-
ease is reached . About 15% of chronic 





Probably six types of acute leukemia 
have been recognized, but for practical 
purposes they may be considered as a 
g roup, since the clinical features and treat-
ment are similar in all types. Frequently 
the predominating type of primitive cell 
cannot be positively identified . 
Clinical Features 
Usually the clinical onset is abrupt, and 
is often considered to be due to an upper 
respiratory infection . There is fever, gen-
eral malaise leading to prostration, and a 
rapidly advancing anemia. Mainly because 
of thrombocytopenia, epistaxis, spongy 
bleeding gums, purpura and other hem-
orrhagic manifestations are common. Sore 
throat and necrotic ulcers in the mouth 
or pharynx are frequent. Lymph nodes 
may be enlarged; the spleen and often 
the liver are enlarged in terminal stages . 
Blood Examination 
1. R.B.C. : There is almost always a 
profound anemia, in which the total 
red cells are 1,000,000 or less, per 
cubic millimeter. 
2. W .B.C.: The distinguishing feature 
is the presence in the blood of a 
large number of mononuclear, non-
g ranular primitive white cells. The 
total count may be as low as 2,000, 
but usually is increased lo 20,000 
or 30,000. 
3. Platelets : Thrombocytopenia is an 
invariable feature, in fact, the plate-
lets are virtually lacking. 
Prognosis 
The condition is invariably fatal, usual-
ly within eight weeks of onset. Occa-
sion ally spontaneous remissions occur and 
last up to six months, and in a few rare 
cases, up to two years. 
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TREATMENT OF LEUKEMIAS 
Doubts are beginning to appear in the 
minds of some authorities as to whether 
treatment of the active case will actually 
prolong life. However, statistics relating 
to a large series of cases will never point 
up the remarkable results which take 
place occasionally in some individual 
cases. It is generally accepted that spe-
cific therapy should be instituted when 
definite symptoms appear or when the 
disease enters a more active phase, and 
not necessarily when the diagnosis is 
made. 
Dr. Osgood's method of treating the 
patient as soon as leukemia is diagnosed 
using "titrated" P32 at regular intervals, 
the dosage being governed by the in-
duced response of the patient, has been 
the object of much interest. Osgood re-
ports mean survival time of slightly over 
four years using "titrated" therapy, in 
contrast to mean survival time of slightly 
over two years using standard therapy. 
Certainly therapy of chronic lympho-
cytic leukemia should be subtle and un-
obtrusive. This is particularly true in 
asymptomatic cases in the older age group 
discovered accidentally. Here no therapy 
is by far the best therapy unless the dis-
ease gets out of hand. Then and only 
then-and here Dr. Osgood disagrees-
should therapy be instituted. 
Treatment of Chronic Leukemia 
It is most important that the differen-
tial diagnosis be accurate, because the 
treatment of chronic forms is entirely dif-
ferent from that of the acute forms. 
The treatment of chronic leukemia of 
all types may be conveniently grouped 
under radiation, chemical agents, and sup-
portive measures. 
1. Radiation : Roentgen rays, radium, 
radioactive isotopes may be used. 
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i) The use of roentgen rays is the 
most satisfactory. X-rays may 
be directed on a regional basis 
to enlarged spleen or lymph 
nodes, or by generalized "spray" 
radiation. In chronic lympho-
cytic leukemia the localized 
form of treatment is prefer-
able. After a series of treat-
ments, the leukocyte count may 
fall to nearly normal, and fur-
ther radiation may not be re-
quired for many months. As 
time goes on, the intervals be-
tween treatments become short-
er and eventually the condition 
will become refractory and 
death ensues. 
Irradiation should not be used 
in acute leukemia at any time. 
It may be safely employed 10 
"aleukemic" patients when the 
leukocyte count is subnormal 
in the beginning. 
ii) Radioactive phosphorus is said 
to be as effective as roentgen 
radiation in the myelocytic type, 
but less effective 1n lympho-
cytic leukemia. The radioactive 
isotope P32 has a half-life of 
about fourteen and one-half 
days. It is given either by mouth 
or· by injection and localizes in 
the marrow, where overdoses 
cause thrombocytopenia, leu-
kopenia and anemia. If the 
facilities are available, it is a 
convenient method of treat-
ment, and no irradiation sick-
ness results. It is of no value 
in acute leukemia. 
2. Chemical Agents: 
i) Ars.enic and benzene: 
These have largely been re-
placed by newer, m~re effec-
tive agents. 
ii) Urethane (ethyl carbamate): 
Satisfactory and sometimes 
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fairly long-lasting rem1sswns 
can be induced in patients with 
chronic myelocytic leukemia, 
but it is of little benefit in the 
treatment of chronic lympho-
cytic or acute leukemias. To be 
effective, therapy with urethane 
must be persevered. Enteric 
coated tablets are often passed 
unchanged; it is best given as 
a syrup with meals, in dosage 
of 2 to 4 grams. Urethane is 
not generally used. 
iii) Nitrogen mustard: 
The use of nitrogen mustard 
1s disappointing 10 the treat-
ment of chronic leukemias. It 
is of more use 1n treating 
Hodgkin's disease. 
iv) T.E.M. (triethylenemelamine): 
T.E.M. is probably the treat-
ment of choice in chronic lym-
phocytic leukemia. Since the re-
sponse of the individual patient 
varies tremendously, T.E.M. 
must be cautiously instituted 
with a single dose of 1 to 2 
milligrams, and the hemato-
logical details be closely fol-
lowed for two or three weeks. 
Some patients have a marked 
decrease in leukocyte count fol-
lowing the first dose. T.E.M. 
is most suitable when the plate-
let · count is not depressed, be-
cause excessive doses cause 
hemorrhagic tendencies due to 
thrombocytopenia. It is of very 
little value 10 chronic myelo-
cytic leukemia, and 1n acute 
leukemia. 
v) Myleran: 
This cytotoxic agent exerts a 
retarding effect on any tissue, 
but a relatively selective re-
tardation of granulopoeisis. It 
is effective in the treatment of 
myelocytic leukemia. Given 10 
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oral daily doses of 4 milli-
grams, it produces general im-
provement in the patient's well-
being, increase in appetite and 
weight gain; definite reduction 
in size of spleen and liver, as 
well as decreased numbers of 
granular leukocytes in peri-
pheral blood. The number of 
lymphocytes in peripheral blood 
is not influenced. Myleran is 
completely ineffective in acute 
leukemia, chronic lymphocytic 
leukemia, and chronic myelo-
cytic leukemia during the out-
pouring of myeloblasts. 
3. St~pporl it'e Measures : 
i) The prevention and treatment 
of minor infections. 
ii) Adequate nutrition and vita-
mins. Folic acid is definitely 
contraindicated. 
iii) Bed rest is indicated only until 
there has been a remission of 
fever . Otherwise patients may 
be as active as their individual 
capacities permit. 
iv) Anemia: 1. The anemia asso-
ciated with chronic myelocytic 
leukemia almost uniformly im-
proves when the leukemic pro-
cess is under control. Trans-
fusions are rarely required. 
2. The acquired hemolytic 
anemia associated with chronic 
lymphocytic leukemia is best 
treated with adrenal cortical 
steroids. 
Treatment of Acute Leukemia 
The treatment of acute leukemia is so 
different from that of chronic leukemias 
that an accurate differentiation between 
these two must be made before treatment 
can be instituted . Roentgen therapy, radio-
active phosphorus, and urethane do more 
harm than good. 
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Probably treatment of patients with 
acute leukemia does not result in any sig-
nificant increase in life span after the 
onset of symptoms. Nevertheless, mori-
bund patients treated by modern methods 
live to enjoy temporary improvement for 
several weeks or months, and there is 
always the hope and possibility that a 
fairly long-lasting remission may be in-
duced. A defeatist attitude must not be 
assumed; these patients should be treated. 
The three types of compounds that pro-
duce remissions in acute leukemia are folic 
acid antagonists (aminopterin), 6-mercap-
topurine, and ACTH or cortisone. With 
any of these agents, relapse occurs and 
drug resistance develops. However, an 
infinitely better response is obtained in 
the child patient than in the adult patient. 
Best results are obtained in acute lympho-
blasti< leukemia. In acute monoblastic 
leukemia only supportive measures are of 
any value. 
1. Aminopterin ( 4-aminopteroylglutamic 
acid) 
This is the most outstanding of 
the folic acid antagonists advocated 
for the control of acute lymphoblas-
tic leukemia. In a few cases, dra-
matic improvements have resulted. 
The drug is given orally in daily 
doses ranging from 0.25 milligram 
to 1 milligram for several days to 
several weeks. Therapy IS discon-
tinued on resumption or normal 
blood and marrow pictures, or the 
development of toxic lesions which 
consist of white, well-demarcated, 
mucous-like patches and ulcers in 
the soft tissues of the mouth and 
intestinal tract. 
2. Cortisone and ACTH 
These hormones have produced 
dramatic temporary improvement. 
If a remission can be produced with 
cortisone and ACTH, it can often 
be prolonged with 1 milligram of 
aminopterin a day. 
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3. 6-mercaptopurine 
This anti-metabolite produces tem-
porary remissions in young adults 
suffering from acute leukemia. It 
is given orally in daily doses of 2.5 
milligram per kilogram of body 
weight. 
Recent reports suggest that in 
children, therapy with cortisone 
and aminopterin should be tried be-
fore 6-mercaptopurine. 
If the patient is acutely ill, therapy 
should be initiated with ACTH and cor-
tisone since the antimetabolites require at 
least three weeks to induce a remission. 
Once a remission has been induced or the 
acute emergency is passed, or if initially 
the patient was not in a critical condition, 
aminopterin (in young children) or 6-
mercaptopurine (in those over 10 years 
of age) should be employed. 
Supportive Measures: 
i) Blood transfusions should be given 
for severe anemia. Hemopoetic 
agents are useless; folic acid is 
harmful. 
ii) Antibiotics are used to control 
secondary infections. 
MARcH, 1956 
iii) Little or nothing can be done for 
the severe thrombocytopenia and 
hemorrhages that accompany the 
disease. 
Under therapy, many children can lead 
happy lives for the duration of their ill-
ness, whereas the untreated patient may 
suffer many painful complications. 
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Agranulocytosis 
Douglas 0. Manners, '56 
INTRODUCTION 
Agranulocytosis is a disorder of the blood characterized by a reduction in 
the number of granulocytes and which may also include a decrease in the abso· 
Jute number of other types of leukocytes . 
The term agranulocytosis. as suggested by Schultz in 1922, described a clinical 
entity that had previously been described by Brown in 1902 and Turk in 1907. 
The clinical picture had been described in detail by Brown and Turk but general 
interest had not been aroused until after Schultz presented six cases in 1922. 
Since then a large number of cases have been described and a more complete 
picture of the disease formed. Only in the more recent years has the relationship 
between agranulocytosis and certain drug administration been clearly shown. 
This condition has come to be known under many different names ; some of 
these include: agranulocytic angina, granulocytopenia, granulopenia, agranulosis, 
agranulocythemia, hypogranulocytosis, idiopathic, malignant or pernicious leuko-
penia and granulocytic hypoplasia. 
ETIOLOGY AND INCIDENCE 
The exact etiology is unknown . Agran-
ulocytosis has been described in countries 
throughout the world, but the majority 
of the reported cases have been in the 
United States and Germany. The disease 
affects all classes with slightly increased 
incidence among the medical profession, 
including physicians, medical students and 
nurses. The white race is seemingly much 
more susceptible than the Negro popula-
tion. The female rate is higher than the 
male, in a ratio of 2 or 3 to 1. The peak 
incidence occurs in the 35-45 year age 
group. 
The majority of cases are acute in char-
acter, although recurrent and chronic cases 
have been described. Ther·e has been no 
evidence of spread by contact and no 
apparent seasonal incidence. Infection 
often accompanies the picture of agranulo-
cytosis and positive blood cultures of var-
ious organisms have been found. How-
ever, it is strongly felt that infection is 
a secondary manifestation of the condi-
tion. Organisms cultured from the blood 
have been injected into animals in an 
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attempt to reproduce the disease, but with-
out success. 
The role of drugs as etiological factors 
has been clearly shown by various investi-
gators. Coal-tar derivatives, organic ar-
senicals and gold salts are among some 
of the known agents. Agranulocytosis 
has been produced only after prolonged 
use of these drugs. The blood picture is 
that of agranulocytosis and frequently 
associated with thrombocytopenia and 
anemia. 
One of the greatest offenders is a drug 
called amidopyrine ("Pyramidon"). It 
was used extensively in Europe until 1933 
in the treatment of arthritis. Cases have 
been reported in which agranulocytosis 
was produced after a single dose of this 
drug and often proved fatal. 
Other drugs causing agranulocytosis in-
clude dinitrophenol and certain sulfona-
mide compounds. The abnormal blood 
picture may be transient but a decrease 
in the number of granulocytes has been 
clearly shown. The course of the drugs 
is usually one of long term. 
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Cases of agranulocytosis have been re-
ported in people who have taken thioura-
cil in the treatment of hyperthyroidism; 
tridione in the control of convulsions ; 
certain antihistaminics (pyribenzamine and 
methaphenilene) and chloramphenicol in 
the treatment of pyogenic infections. 
Within the past year, phenylbutazone 
("Butazolidine") , used in the treatment 
of arthritis, has been reported to cause 
agranulocytosis . Recently, chlorpromazine 
("Largactil") has been proven to cause a 
few cases of agranulocytosis. 
Several cases of idiopathic agranulocy-
tosis have been reported without a his-
tory of drug therapy. A definite etio-
logical agent might have been discovered 
in some of these cases if the history and 
investigation had been more thorough. 
PATHOGENESIS 
It has been suggested by Kracke that a 
benzene ring with an attached "NH" or 
"NH2" group produces an oxidation pro-
duct which in turn produces a leukotoxic 
effect. It has been postulated that these 
toxic drugs may produce their effect by 
interfering with certain enzyme systems 
in the tissues. 
In association with agranulocytosis, cer-
tain drugs frequently cause other signs 
such as edema, rash, urticaria and an 
asthmatic response. These manifestations 
have suggested the possibility of an 
allergic process. Tests to produce an anti-
body against amidopyrine in the hyper-
sensitive individuals have been performed 
with negative results. Scratch tests, patch 
tests, intradermal tests and transfer tests 
have been essentially non-contributory to 
the theory of an allergic process. 
The primary disturbance in the bone 
marrow in agranulocytosis is a deficiency 
of juvenile and segmented neutrophilic 
leukocytes; thus, a "maturation arrest" be-
yond the stage of myeloblasts. However, 
it is unlikely that this is the only factor 
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because a leukopenia may develop within 
six hours after a dose of amidopyrine. 
Peripheral destruction of polymorphonu-
clear leukocytes or " pavementing" of leu-
kocytes to the capillary endothelium must 
be acting as well to produce the granulo-
cytic deficiency. Thus, the exact mechan-
ism or mode of action remains r, complex 
picture with a disturbance of the bio-
chemistry of hemopoietic tissue the basis 
of the pathogenesis. 
CLINICAL PICTURE 
The onset may be sudden with general 
malaise, high fever , chills, rapid pulse and 
often stomatitis . The patient may then 
have relatively few symptoms except for 
prostration and fatigue. During this stage 
leukopenia results, particularly granulo-
cytopenia. The patient may then become 
jaundiced, have gangrenous ulceration of 
the gums, tonsils, soft palate, lips, pharynx 
or buccal mucosa. Less frequently the 
skin, nose, vagina, uterus, rectum or anus 
are involved. There may be splenomegaly. 
Infection soon develops, due to lowered 
resistance in the absence of granulocytes. 
Bronchopneumonia or a septicemia usually 
causes a fatal termination . 
Recurrent or cyclic cases have been 
recorded in which the acute attacks have 
been followed by asymtomatic intervals 
of weeks or months with an essentially 
normal leukocyte count. After the second 
or third attack the outcome is usually 
fatal. In the so-called "chronic" cases, the 
periods of a relatively normal leukocyte 
count are followed by attacks of malaise, 
headache, dizziness, fatigue and prostra-
tion but may occur without fulminating 
angina. 
Laboratory Findings 
( 1) Blood Picture 
The predominant finding is that of 
granulocytopenia but an associated de-
crease of the other leukocytes is usually 
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found. In acute cases, the count is initially 
less than 2000 per cu.mm. and then fre-
quently drops to less than 1000 per 
cu.mm. Cases have been recorded with 
white counts as low as 50 and a complete 
absence of granulocytes. The granulo-
cytes may have a pyknotic nucleus with 
vacuolated cytoplasm containing poorly 
stained granules. The presence of myelo-
cytes in the blood only occurs after re-
covery begins. The lymphocyte is the pre-
dominating leukocyte found in the blood 
smear; occasionally, a relative increase in 
the monocytes is observed. 
In the recurrent or cyclic forms of 
agranulocytosis, the leukocyte count rarely 
drops below 2000 per cu.mm. and the 
granulocytopenia is less pronounced. 
In the typical case there is no anemia 
or thrombocytopenia, and the bleeding 
and clotting times are normal. There is 
no variation in appearance of the erythro-
cytes or in the reticulocyte count. How-
ever, the sedimentation rate is greatly ele-
vated and the icteric index may be 
increased . 
(2) Bone Marrow 
The examination of the bone marrow 
shows normal erythropoietic tissues with 
a normal number of megakaryocytes. The 
microscopic picture may be one of mod-
erate hypoplasia or of hyperplasia. The 
outstanding feature of the marrow is the 
lack of granulocytes which include not 
only polymorphonuclear cells but also the 
metamyelocytes and the myelocytes. An 
increase in the plasma cells, lymphocytes 
and reticulum cells may be seen but is not 
striking. 
(3) Urine 
There may be a trace of albumin but 
the urine is otherwise normal. 
( 4) C11/tures 
Blood cultures are often positive for 
a great variety of organisms. The current 
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optmon is that these are secondary in-
vaders due to the lowered tissue resistance 
in the absence of granulocytes. 
Blood cultures often contain upper 
respiratory organisms. 
DIAGNOSIS 
The early symptoms of agranulocytosis 
simulate many other conditions so closely 
that it is often difficult to diagnose the 
condition before a septicemia has de-
veloped. It is essential that a physician 
be aware of the condition when any drug 
known to produce agranulocytosis is used 
and he should therefore be suspicious of 
any unusual symptoms. White blood cell 
counts should be done on these patients 
receiving the drug at least twice each 
month during therapy. 
DIFFERENTIAL DIAGNOSIS 
When local symptoms in the buccal 
cavity or a pharyngitis are present it is 
essential to differentiate the cause. In the 
majority of infections of the ' oral cavity 
and pharynx, leukocytosis is found . In 
other conditions such as typhoid fever, 
rubella, rubeola and undulant fever that 
present a leukopenia, the more gradual 
onset, and the characteristic signs and 
symptoms distinguish them from agranu-
locytosis. In any condition with a leuko-
penia it is unlikely that the leukocyte 
count would reach as low a level as found 
in this particular disease. 
Some of the blood dyscrasias present a 
leukopenia; acute "aleukemic" leukemia 
and aplastic anemia can be recognized by 
the appearance of an anemia and thrombo-
cytopenia. Leukemia often presents with 
immature leukocytes in the blood and 
adenopathy and splenomegaly. In infec-
tious mononucleosis, extreme leukopenia 
is unusual; the lymphocytes are atypical 
and there is a positive heterophil anti-
body test (Paul-Bunnell Test). 
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PROGNOSIS 
Before the advent of sulfonamides and 
antibiotics, the mortality in agranulo-
cytosis was between 75 - 90 per cent and 
was greatest in elderly patients. The out-
come is very poor if the patient becomes 
drowsy, confused, has profound prostra-
tion , jaundice, necrosis of the skin and a 
leukocyte count below 1000 cu.mm. with 
the absence of all granulocytes. 
Death usually occurs from secondary 
complications such as sepsis, pneumonia 
or hemorrhage following necrosis . 
Any improvement in the condition is 
manifested by the appearance of leuko-
cytes of the granular series in the blood; 
myelocytes are the first to appear and 
then the metamyelocytes with myeloblasts 
on occasion. The segmented neutrophils 
are the last to appear. The appearance of 
monocytes that persist is thought to be 
a favorable prognostic omen. The leuko-
cytic reaction may be marked and rapid 
with a leukocytosis of 15,000 per cu.mm. 
most often found. 
MANAGEMENT 
The actual management is difficult be-
cause many cases are extremely ill before 
any treatment is initiated or the patient 
is dead before any benefit can be derived. 
In many cases more than one remedy is 
used and so it is often difficult to evalu-
ate which one actually produces a bene-
ficial effect. Some observers report good 
results with certain drugs but other in-
vestigators have not been able to re-
produce their findings . 
A . Prophylaxis 
The most important single factor in 
the treatment is caution in the use of any 
drug or related drugs capable of produc-
ing agranulocytosis. If the drug has been 
proven to cause the condition, the physi-
cian should be on the lookout for any 
leukopenia while the treatment is being 
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carried out. The drug (or drugs) should 
be immediately stopped if granulocyto-
penia presents itself. The structural for-
mula should be examined and if the sub-
stance contains one or more " benzamine" 
groupings, the possibility of agranulo-
cytosis should be seriously considered. 
B. General Care 
Symptomatic treatment is essential and 
of great importa-nce. The diet should be 
adequate with a liberal vitamin supple-
ment. The possibility of any secondary 
infection should be minimized. The mouth 
and any local lesions should have metic-
ulous care. The mouth and throat may 
be sprayed with a saturated solution of 
potassium chlorate; the ulcerated areas 
may be swabbed with a solution of copper 
sulfate ( o.65 gms. to 30 c. c.) . 
C. Specific Treatment 
1. Antibiotics and Sulfonamides 
The use of antibiotics is perhaps 
the most beneficial specific agent. Penicil-
lin is of great assistance in preventing an 
overwhelming sepsis. The actual reappear-
ance of granulocytes probably occurs spon-
taneously after the offending drug has 
been removed. Although the sulfona-
mides have been known to cause agranu-
locytosis, they should not be withheld if 
they are not the offending agent. With 
the advent of penicillin and the broad 
spectrum antibiotics, however, it is sel-
dom necessary to use the sulfonamides. 
2. Nttcleic Acid Derivatives 
Of prime importance in agranulo-
cytosis is the stimulation of granulocyte 
production . Compounds such as sodium 
nucleinate or pentonucleotide are no 
longer in use. 
3. ACTH and Cortisone 
These hormones have been re-
ported to hasten recovery in some cases. 
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Their use is based on the possibility of a 
hypersensitivity reaction being involved in 
the pathogenesis. They constitute a double-
edged sword, since they further depress re-
sistance to infection. Antibiotic coverage 
must be maintained while the patient is 
being treated with either hormone. A 
satisfactory dosage is 50 mgm. of corti-
sone orally or intramuscularly four times 
daily, or 20 to 30 mgm. of ACTH by 
slow intravenous drip during an eight 
hour period each day. 
The danger of using ACTH and corti-
sone must be weighed carefully in each 
case against the possible but uncertain 
beneficial effect on the agranulocytic 
process. 
4. Bone Marrow 
Yellow bone marrow and marrow 
extracts have been given orally with the 
hope of containing a marrow stimulating 
factor. The actual benefit produced has 
been questionable although the origina-
tors of this treatment report promising 
results. 
5. Blood Transfusions 
Transfusions of normal whole 
blood, blood from patients with leukemia 
or leukocytosis have been used, but with 
inconclusive results. 
6. Liver Extract 
Large doses of liver extract given 
intramuscularly have been used in an 
attempt to overcome any anemia present. 
The actual leukocyte formation (if any) 
has not been clearly demonstrated. 
7. Splenectomy 
Splenectomy has been recom-
mended in some c h r o n i c cases of 
agranulocytosis. 
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8 . British Anti-Lewisite 
Where the granulocytopenia has 
been produced by arsenic or gold, B.A.L. 
has been given in doses of 1.5 mls. of a 
10 per cent solution in oil six times daily 
for the first two days and then twice 
daily for another 8- 10 days. B.A.L. has 
a pronounced beneficial ·effect in heavy 
metal poisoning and it is on this assump-
tion that the substance is given in the 
treatment of this condition. 
Conclusion 
Many other measures have been tried 
in the treatment of agranulocytosis but 
most have seemed irrational. When the 
precise etiology has been discovered, then 
a specific form of treatment may be made 
available. 
It must be emphasized that prophylaxis 
is the best "cure" and that drugs known 
to cause this condition should only be 
used as a calculated risk. 
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Bleeding Disorders 
D. B. MELTZER, B.Sc., M.D., F.R.C.P. (C) 
INTRODUCTION 
Bleeding disorders are uncommon, but it is most important that they be 
recognized as such. Recognition may lead to diagnosis, and this in turn to an 
available treatment; above all, recognition may forestall tragic complications of 
surgery - ' 'bleeders'' are always poor surgical risks. A great deal has been 
learned about the mechanisms of blood coagulation since the classical theories 
were proposed . To the average physician this newer knowledge appears to be 
very complex ; however, on further careful study it becomes apparent that the 
mechanisms of the various "bleeding" disorders are much better explained on 
the basis of this newer knowledge. Therapy based on replacement of demon-
strable defects is daily becoming more effective. 
One great difficulty in understanding blood coagulation, and even in reading 
about it, is terminology . Each factor has several names, and in at least one in-
stance a single factor has been needlessly separated into two. The situation is for-
tunately ever more hopeful in that a more orderly pattern is evolving, and almost 
every month another piece of the puzzle is put into place. 
It is not the purpose of this paper to elucidate the mechanism of blood 
coagulation, but rather to present a small amount of working theory, and to 
attempt to apply this to some of the more simple investigative techniques, with 
a view to the "screening" of bleeding problems. 
The classical scheme of coagulation is 
of course rendered inadequate by present 
day knowledge, but it still serves as a use-
. ful framework upon which to build the 
more complex structure which is con-
stantly being elaborated. There are three 
main steps: 
1. Platelets + foreign surface -+ throm-
boplastin (i .e. the generation of throm-
boplastin) 
2. Thromboplastin + prothrombin + 
Ca+ + -+ thrombin (i.e. generation 
of thrombin) 
3. Thrombin + fibrinogen -+ fibrin 
(clot) (i .e. generation of fibrin). 
Ordinarily this system of coagulation is 
held in abeyance, but when need arises 
it must become active and reach its pur-
posed end quickly, perform its function, 
then bow out. The newer factors described 
help to explain how this is possible, how 
the clotting starts slowly, then acceler-
ates, and finally that a clot does not 
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propagate infinitely. The normal person 
is able to set up such a system of defence 
against bleeding which will protect him 
from all but the major injuries to blood 
vessels. 
Vascular and Platelet Factors 
It is apparent that when a tissue IS m-
jured, with laceration of blood vessels, a 
mechanism for hemostasis must be put 
into operation at once. The initial re-
action of the blood vessels in the dam-
aged area is constriction, which is med-
iated by axon reflexes f rpm the noCI-
ceptive stimulus. The effect is to slow 
up the local circulation, and this may aid 
in the agglutination of platelets. The 
tissue injury also leads to liberation of 
thromboplastic substances. The agglutina-
tion of platelets leads to the release of 
a vasoconstrictor substance (angiotonin) 
which causes a generalized vasoconstric · 
tion to the area, and also to the release 
of thromboplastic substances and acceler-
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ator factors of coagulation. The platelet 
and tissue factors form thromboplastin 
and a system is set up which results in a 
mechanical plug (clot) at the site of blood 
vessel injury. The clot eventually retracts, 
completing temporary hemostasis. Per· 
manent hemostasis involves the organiza-
tion of the clot, and its eventual removal 
( fibrinolysis) and recanalization of the 
blood vessel, with laying down of a new 
endothelial lining. 
In discussing the vascular factors, it is 
apparent that despite any coagulation de-
fect , if the vascular wall be intact spon-
taneous bleeding cannot occur. The cor-
ollary is also true, that with a perfectly 
normal coagulation system, but with a 
blood vessel wall defect spontaneous 
bleeding can, and does, occur. These vas-
cular factors are understood only poorly. 
They include an intracellular cement sub-
stance, collagen fibres, fibrous tissue, en-
dothelial lining, and neuro-humoral con-
trol. Scurvy is a good example of such 
a defect, in which ascorbic acid is insuffi-
cient for maintenance of the ground sub-
stance. A similar defect is probable in 
senile purpuras. Congenital defects of the 
small blood vessels probably explain the 
hemorrhagic diathesis of "vascular pseu-
dohemophilia" (Von Willebrand's dis-
ease), and hereditary hemorrhagic tel-
angiectasis, idiopathic hematemesis, and 
melena. In " primary" pulmonary hemo-
siderosis there is said to be an immuno-
hematological factor .2 It is postulated 
that the defect is in contractility of the 
vessels in the latter group of diseases. 
It is of great interest that primary pul-
monary hemosiderosis and " vascular pseu-
dohemophilia" manifest as episodic bleed-
i~g, with intervals in which bleeding 
times are normal. 
Hypertensive individuals may also show 
purpura. Here there are several factors 
at play ; frequently there is a defect of 
the walls of the arterioles, increased pres-
sure opposes contraction and promotes 
flow through a defect. Such people may 
have a positi ve tourniquet test. 
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Inspection of the skin and mucous 
membranes in hereditary hemorrhagic tel-
angiectasia shows dilated capillary and 
arteriolar loops which can be emptied-
obviously if one of these is injured it is 
incapable of contracting sufficiently, and 
therefore prolonged bleeding ensues. In 
"vascular pseudohemophilia", by using 
special but simple techniques, one can see 
under the microscope the tortuous capil-
lary loops in the nail beds (in vivo)} 
The diagnosis of these two disorders thus 
can be made quite easily if one takes an 
adequate personal and family history, and 
completes a few simple tests. The treat-
ment of these congenital disorders has, 
to date, been unsatisfactory. Local pres-
sure, if possible, is the best means of 
achieving hemostasis ; as an alternative, 
cautery may be used. Diagnosis is, how-
ever, most important in order that neces-
sary precautions may be exercised. 
Thrombocytopenic purpura is a more 
complex situation, involving both vascular 
and coagulation defects. It is possible 
that some hormonal control exists in this 
situation since adrenal steroids and ACTH 
will usually control the purpuric manifes-
tations without necessarily improving the 
platelet count.4 As was mentioned above 
the platelets, in addition to having a~ 
angiotonic effect, apparently release a 
thromboplastin precursor and possibly an 
accelerator of prothrombin conversion, 
and of fibrinogen conversion ; as well they 
appear to release an "anti-heparin" sub-
s~ance . It is apparent then, that qualita· 
tl.ve ~s well as quantitative platelet defi-
oenoes may affect clotting. In throm-
bocytoasthenia (Glanzman's disease) there 
are normal numbers of platelets, but 
these are of bizarre morphology and are 
deficient in function . 
Platelet deficiency manifests itself in 
several ways : 
1. Purpura (i .e. spontaneous bleeding 
into skin and mucous membranes) 
2. Prolonged bleeding time 
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3. Poor clot retraction 
4. Diminished prothrombin consump-
tion 
5. Positive tourniquet test 
6. Poor fibrinogen conversion. 
Plasma and Serum Factors 
There are present in the plasma several 
important coagulation factors. These may 
be divided into three groups:4 
1. Thromboplastin antecedents 
(a) Antihemophiliac globulin 
(A.H.G.) 
(b) Plasma thromboplastic com pon-
ent (P.T.C. or Christmas factor) 
(c) Plasma thromboplastic ante-
cedent (P.T.A.) - and prob-
ably several others 
2. Prothrombin, calcium and fibrino-
gen 
3. Accelerator factors (labile and stable 
factors) 
As well, there is a system controlling the 
lysis of clot, which will be discussed later. 
All of the above are present in the 
serum except fibrinogen, in concentra-
tions related directly to their utilization 
during coagulation; there is also a stable 
component, serum accelerator, thrombin, 
(and an inactive, but potentially active, 
metathrombin complex). 
Coagulation Theory 
To discuss coagulation per se, there 
are three phases, as is mentioned in the 
classical theory. The first phase, a slow 
phase, involves platelet and tissue factors 
plus the plasma thromboplastin ante-
cedents interacting to form thrombo-
plastin. Defects in this phase are de-
tectable by the thromboplastin genera-
tion test; this test, however, is not within 
the compass of the average laboratory. 
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The second phase (still a slow phase) 
depends upon the production of throm-
boplastin, which interacts with prothrom-
bin, calcium, labile and stable factors to 
form thrombin. If there is failure of for-
mation of adequate thromboplastin little 
thrombin will be formed, i.e. prothrom-
bin will not be sufficiently used up and 
will remain in higher than normal levels 
in the serum. This is the basis for the 
prothrombin consumption test, i.e. the 
one stage prothrombin time of the serum 
is measured, using an exogenous source 
of fibrinogen. A diminished prothombin 
·consumption, then, indicates a defect in 
phase one; thus it is a good screening 
test for the hemophiliac diseases, and for 
platelet deficiencies. This test can be car-
ried out in any hospital laboratory. 
Defects of the second phase show up 
as a prolongation of the prothrombin 
time. This finding usually indicates de-
liberate anticoagulation, or acquired hypo-
prothrombinemia from liver disease. It 
is also seen in association with obstruc-
tive jaundice. Defects of labile and stable 
factors also affect the prothrombin time, 
and one can usually deduce which factor 
is at fault by adding fresh plasma, stored 
plasma and serum. 
The third (accelerated) phase of co-
agulation involves acceleration of the re-
actions just described, and pari passu 
reaction between fibrinogen and throm-
bin to form fibrin clot, with the aid of 
a platelet factor (Platelet factor No. 2). 
This whole reaction is autocatalytic, thus 
ensuring abundant factors. It appears 
that the basic trigger is the formation of 
a small amount of thrombin, which thus 
acts upon platelets, labile, and stable fac-
tors. It is apparent that once such an 
autocatalytic agency is set up, there must 
be "some way of stopping it", lest a com-
plete clotting of the vascular tree occur. 
Owren has postulated an inhibitor sub-
stance against labile and stable factors. 
Fibrin clot actively removes thrombin, 
thus the main cog of the autocatalytic 
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mechanism is removed at an ever increas-
ing rate until further fibrin formation 
must cease. The thrombin is later re-
leased at a slow rate so that it can be 
inactivated by anti-thrombin substances. 
Meta·thrombin is the name given the re-
versible end product of the absorption of 
thrombin by this group of substances. 
Antithromboplastic Substances 
Antithromboplastic substances are re-
ceiving prominent notice in the newer 
literature) Tocantins has postulated that 
an antithromboplastic substance excess is 
the fault in hemophilia, rather than a de-
ficiency of A.H.G., as is postulated by 
most other coagulationists. Another, but 
entirely different, thromboplastin inhibi-
tor may develop in association with a 
variety of conditions: 
1. Multiple transfusions (especially in 
hemophiliacs) 
2. Pregnancy with an Rh incompatible 
product 
3. Pemphigus 
4. Lupus erythematosus disseminata 
Etcetera. 
In such situations there may be a result-
ant severe hemorrhagic diathesis. 
Fi'brinol ysis 
Once the clot is formed, it must of 
course be removed after it has completed 
its function; this is brought about by a 
fibrinolytic system.5 The circulating plas-
ma carries profibrinolysin, which may be 
activated by bacterial filtrates (such as 
streptokinase) and by normally occurring 
tissue fibrinolysokinase ( which is par-
ticularly abundant in lung and uterine 
tissue). The active end product is fibri-
nolysin, which are inhibitors of clot lysis. 
The mechanism appears to have at least 
some endocrine control, in some way 
mediated through the pituitary gland, in-
deed ACTH or adrenal steroids may 
64 
quickly diminish abnormal fibrinolytic 
activity. This phase of coagulation is 
mentioned because a severe bleeding dia-
thesis may ensue from excessive fibrino-
lytic activity. This occurs in "stress" sit-
uations, hemorrhage, trauma especially to 
lungs, shock, extensive surgery, leukemia, 
and with carcinoma of prostate. 
Screening Procedures 
In screening a possible bleeding prob-
lem it is advisable to proceed stepwise, 
and to think, as much as possible, of the 
various phases of coagulation. There are 
a number of relatively simple laboratory 
tests which are of considerable help, if 
properly carried out and correctly inter-
preted . I shall attempt to describe these 
tests briefly, and to mention some of the 
other pertinent tests. 
The history obtained from the patient 
is not a laboratory procedure, but it is a 
most important aspect of the investiga-
tion of a bleeding problem. One should 
enquire specifically about bruising ten-
dency, bleeding from nose and gums, 
stools, urine, excessive bleeding from 
small".abrasions, etcetera, and in females, 
menorrhagia. The family history is of 
great importance, as "bleeders" are usually 
well known in a family group, and it 
is important to know the sex of the 
"bleeders" and whether they are of ma-
ternal or paternal lineage. 
Cases with a family history of both 
male and female bleeders (usually mild) 
whose only demonstrable defect of co-
agulation is a prolonged (variably so) 
bleeding time, and whose bleeding can 
be arrested only by local pressure, fall 
into the group of hereditary purpuras 
entitled "vascular pseudohemophilia" or 
Von Willebrand's disease. The diagnosis 
is confirmed by examination of the nail 
bed under oil and using a blue light-
the characteristic tortuous arterioles are 
readily observed. This disease illustrates 
the importance of using standard tech-
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niques for even such a "simple" test as 
a bleeding time. The Ivy technique6 is 
a useful standard, and lends itself to com-
parisons. In this technique a manometer 
cuff is placed about the upper arm and 
inflated to 40 mm. of mercury maintained 
at that level, an avascular area on the 
volar surface of the forearm is selected 
carefully cleaned with alcohol, and al~ 
lowed to dry. With a sharp scalpel blade, 
a cut is made 2 mm. deep and 2 mm. 
long, and at this moment a stop watch 
is started . At 30 second intervals a piece 
of filter paper is lightly placed over the 
cut. In this way a permanent record is 
made. When no more blood attaches to 
the filter paper the bleeding time is 
recorded . The normal value varies from 
one-half minute to 6 minutes. This method 
is recommended over the Duke (ear lobe) 
method for 3 main reasons : 
1. Permanent record is obtainable 
2. It is standardized for venous pres-
sure, and also for depth and size 
of the cut 
3. Bleeding is easily controlled in this 
area (and in true bleeders this may 
be very important. 
Prolongation of the bleeding time is seen 
in cases with a defect (primary) of the 
vascular wall, as in "pseudohemophilia", 
scurvy, and as well in cases with a sec-
ondary defect such as in thrombocyto-
penia and thrombocytoasthenia. 
With the manometer cuff still in place 
as for the above test, one may carry out 
the tourniquet test for capillary fragility. 
In this procedure the forearm is care-
fully inspected for skin lesions which 
might be confused with petechiae, then 
the manometer is inflated to half way 
between the systolic and diastolic pres-
sures and left at this level for 5 minutes 
(or up to 10 minutes if the patient can 
tolerate this). Various methods of record-
ing the test are used; commonly, an area 
the size of a twenty-five cent piece is 
selected about 3 em. below the antecubital 
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fold. A count of petechiae is made in 
this area after the pressure has been re-
leased for 2 minutes. Any count above 5 
is significant in men, above 10 in women. 
This test is positive in scurvy, senile pur-
pura, and in thrombocytopenia when the 
platelet count is below 70,000 by the 
Dameshek method or 35,000 by the direct 
method. 
The clotting time of whole blood is a 
procedure readily carried out in the office 
or at the bedside. It should be done care-
fully in ordet to avoid as many variables 
as possible.7 Four clean dry test tubes 
2Yz " x %" are used, a clean venipuncture 
is made with a sharp # 19 gauge needle, 
and a small quantity of blood is with-
drawn. The tourniquet is then removed, 
a paraffined or siliconized syringe is at-
tached to the needle, and 4 cc. of blood 
are withdrawn gently, at which time the 
stop watch is started . 1 cc. of blood is 
placed into each test tube, and these are 
kept at body temperature, preferably in 
a water bath, but if need be, this can be 
in a shirt pocket. The tubes are tilted at 
V2 minute intervals, and the clotting time 
of each is that point when the clot holds 
together when the tube is inverted . The 
clotting time is the average of the four 
tubes. Normal value by this method is 
5 to 10 minutes for ordinary tubes, and 
18 to 25 minutes with siliconized test 
tubes. The latter is the more sensitive 
test, and detects a coagulation defect more 
readily - this is especially so in the 
hemophiliac group of diseases . These 
samples may be further used, for the pro-
thrombin consumption test, or they may 
be left in a water bath at 3 7° C. for 24 
hours for investigation of clot retraction 
and fibrinolysis. Of course, the observa-
tion of the clot gives at least some idea 
of the adequacy of the fibrinogen level. 
The clotting time is usually abnormal in 
the hemophiliac group, in cases with 
idiopathic or induced anticoagulants, ex-
treme fibrinolysis, and in cases with gross 




The second phase of coagulation is ob-
served by the estimation of plasma pro-
thrombin. This can be carried out in an 
office, but very few offices have the 
necessary equipment; however, it should 
be available in any clinical laboratory. It 
is not within the scope of this paper to 
discuss anticoagulant therapy, but it must 
be realized that this test is important in 
screening bleeders. Elevated prothrombin 
times are of course most commonly seen 
in anticoagulant therapy with coumarin 
derivatives (and it must be re:tlized that 
these drugs may be taken unwittingly, 
for the purpose of malingering, or even 
with suicidal intent) . In severe liver dis-
ease there may be a diminished pro-
thrombin level (and also of factor VII)-
this need be only slight to be of signifi-
cance. Owren has described a bleeding 
diathesis caused by labile factor deficiency 
in which an alteration in prothrombin 
time is demonstrable. In obstructive jaun-
dice, because of the poor absorption of 
vitamin K, there is an elevated pro-
thrombin time, which can be corrected by 
parenteral administration of vitamin K-
and indeed this may be a useful test of 
liver function and a tool in the differen-
tial diagnosis of jaundice. In hemorrhagic 
disease of the new born there is a pro-
longed prothrombin time which can be 
corrected by parenteral administration of 
vitamin K. The exact mechanism of this 
defect has yet to be elucidated, but it does 
appear that the prophylactic use of vita-
min K has cut down the incidence of 
this disease, so presumably there is a de-
fective absorption of vitamin K rather 
than poor utilization of it. 
To backtrack for a moment to the first 
phase of coagulation, this phase is ob-
served by the thromboplastin generation 
test8 which is not easily carried out, and 
by the prothrombin consumption test9 
which is readily performed. In this latter 
test, blood is allowed to clot under stand-
ard conditions, and after a set period of 
time the prothrombin level of the serum 
is measured . Thus if thromboplastin is 
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deficient, prothrombin will not be con-
sumed to a normal extent in clotting, and 
hence will remain at high levels in the 
serum. This test then is abnormal in dis-
eases with quantitative and qualitative de-
fects of platelets, and in the hemophiliac 
group of diseases. 
The platelet count may be difficult to 
perform in the office or even in a labora-
tory where it is an infrequent test, but a 
good substitute is the examination of a 
carefully made and well stained blood 
smear, preferably on matched coverslips. 
Ordinarily one sees one or several plate-
lets in almost every oil immersion field, 
whereas in thrombocytopenia, several 
fields must be viewed before a single 
platelet is observed. The smear also per-
mits morphological study of the platelets. 
Thus the stained blood film is an im-
portant, and easily carried out, screening 
test. 
Fibrinogen estimations are difficult, but 
observation of the clot is helpful, and 
more recently a simple screening test for 
fibrinogenopenia has been made available 
commercially-this is called "Fibrindex"-
and should prove to be very useful and 
time saving. 
Because of the recent publicity about 
hemorrhagic diathesis in association with 
fibrinolysins,~ I shall make brief mention 
of this subject. Fibrinolysis is seen in 
many circumstances such as: 
1. Pregnancy 
2. Hemorrhagic shock and trauma 
(especially to chest) 
3. Extensive surgery (again especially 
to chest) 
4. Premature separation of placenta 
(here there is another mechanism 
of intravascular clotting because of 
thromboplastic embolization in many 
instances). 
5. Leukemia 
6. Liver disease, especially cirrhosis 
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7. Transfusion reactions 
8. Metastatic carcinoma of prostate. 
The detection of fibrinolysis is exceed-
ingly simple. A sample of blood is left 
to clot in a clean dry test tube at 37° C. 
for 24 hours, and is observed at regular 
intervals. If there is lysis of the clot be-
fore the end of 24 hours, there must be a 
fibrinolysin present. If, on the other 
hand, no clot forms, there must be com-
plete afibrinogenemia, or a circulating 
anticoagulant. If the latter be the case, 
addition of this person's plasma will pro-
long the clotting time of normal whole 
blood. 
Comment 
This discussion has of needs been ram-
bling. I have attempted to deal with the 
generalities of blood coagulation, with a 
view to clarifying some of its "mysteries", 
and to present what is, I hope, an easy 
plan for use in screening "bleeders". To 
recapitulate, the history re personal and 
family bleeding tendencies is all import-
ant. The bleeding, clotting, and pro-
thrombin times (of both plasma and 
serum), examination of a well stained 
blood film, and observation of the clot, 
are some of the important laboratory 
steps. If the findings are properly inter-
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preted, one can determine at least whether 
or not a bleeding problem exists, and pos-
sibly why it exists and what can be done 
about it. 
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and the Related Disorders 
MERVYN LAKIN, Meds '56 
INTRODUCTION 
Hemophilia has been defined as a clinical disorder characterized by a tendency 
to bleed and by a prolonged clotting time of whole blood which is strongly 
familial and is almost exclusively present in males. Our increasing knowledge of 
the mechanism of the coagulation of blood has led to the discovery of syndromes 
almost indistinguishable from classical Hemophilia, but which are amenable to 
differentiation and characterization by special laboratory studies. This paper is 
intended to discuss classical Hemophilia, which shall arbitrarily be referred to as 
Anti-hemophilic globulin (AHG) deficiency, Plasma Thromboplastin Component 
(PTC) deficiency or " Christmas Disease," and Plasma Thromboplastin Antecedent 
(PTA) deficiency. 
PATHOLOGICAL PHYSIOLOGY 
Two major theories have been advanced 
to explain the etiology of the bleeding 
in Hemophilia and the related disorders. 
The first, and more widely accepted 
theory, states that Thromboplastin re-
quires for its formation platelets, calcium, 
AHG (thromboplastinogen), PTC, and 
PTA. With dassical hemophilia, the 
AHG which is required for thrombo-
plastic activity is missing, deficient, or 
defective. It has been postulated recently 
that AHG must be activated by thrombin 
before it will react with platelets. Since 
thrombin is directly or indirectly respon-
sible for the disintegration of platelets, 
and since in this condition only a minute 
amount of thrombin is formed , the plate-
lets remain intact and defective hemo-
stasis results. Similarly, the deficiencies 
of PTC and PTA will cause defective 
hemostasis. The varying degrees of sever-
ity can be accounted for by different de-
grees of insufficiency of these components. 
The second theory has been postulated 
by Tocantins . He believes that thrombo-
plastin formation requires two compon-
ents: a cephalin-like lipid factor con-
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tained in platelets; and a plasma factor 
in the form of a conjugate of a platelet 
co-factor with a lipid inhibitor. He vis-
ualizes that the platelets are disrupted 
releasing the cephalin-like lipid and that 
the co-factor/lipid inhibitor conjugate is 
dissociated. The interaction of these com-
ponents causes the formation of a cepha-
lin-like lipid /co-factor conjugate which is 
plasma thromboplastin . If there is a dis-
proportionate increase in the lipid in-
hibitor conjugated with the plasma co-
factor of platelets, the amount of platelet 
material available is insufficient to over-
come the excess of inhibitor and the 
interaction of platelet lipid and its plasma 
co-factor is prevented or greatly slowed, 
causing little plasma thromboplastin to be 
formed. This, Tocantins believes, is the 
fundamental defect of classical Hemo-
philia. According to this theory, various 
degrees of excess of the antithrombo-
plastin activity above normal, result in the 
different degrees of severity of the con-
dition. If there is a disproportionate 
decrease in platelet plasma co-factor with 
which the lipid inhibitor is conjugated, 
slower than normal thromboplastin for-
mation results. This may explain the 
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pathogenesis of PTC deficiency since 
Tocantins believes that the platelet co-
factor is probably PTC. Here, too, one 
gets various degrees of severity due to 
various degrees of insufficiency of the 
platelet co-factor. 
GENETICS 
Both Hemophilia and PTC deficiency 
are hereditarily similar. The trait is trans-
mitted as a sex-linked recessive character-
istic carried by the female and transmitted 
to the male. The gene is located in the 
X chromosome. If a hemophilic male 
(XY) marries a normal female (XX), the 
genotypes of their children will be XX, 
who will be female carriers, and XY, who 
will be normal males. If a normal male 
(XY) marries a hemophilic carrier fe-
male (XX) , the genotypes of their chil-
dren will be as follows: XX, a normal 
female; XX, a hemophilic carrier female; 
XY, a normal male ; and XY, a hemo-
philic male. It i.:_ possible that if a 
hemophilic male (XY) marries a carrier 
female (XX) , one of their children may 
have a genotype of XX, which would 
make her a hemophilic female . Such cases 
have recently been reported. 
Only 50-75 % of hemophilics give a 
family history of the disease. The reasons 
for this are threefold: first, an inadequate 
or inaccurate history may have been ob-
tained; secondly, only female children 
may have been born for several genera-
tions ; and finally, some consider that a 
gene mutation might occur in which the 
normal gene becomes a hemophilic gene. 
PTA deficiency is transmitted as an 
autosomal, dominant trait. The disease 
may be transmitted by either males or 
females to male or female progeny. 
PROPERTIES 
Different fractions of the blood pro-
duce various findings with respect to 
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AHG, PTC, and PTA activity. The 
plasma fraction contains all three factors . 
Normal serum does not contain AHG, 
but does contain PTC and PTA. The 
AHG activity is greatest in Cohn frac-
tion I, whereas both PTC and PTA 
activity are greatest in fractions III and 
IV-1. Barium sulfate treated normal 
plasma and Seitz filtered normal plasma 
show both AHG and PTA activity but 
no PTC activity. Fractional separation of 
normal plasma by ammonium sulfate 
shows that AHG activity is greatest in 
the 0-25 % fraction , while PTC activity is 
greatest in the 33-50% fraction, and PTA 
in the 25-33 % fraction. 
It is of great importance that AHG is 
consumed in the clotting process while 
PTC and PTA are not consumed, but 
rather appear to be potentiated by the 
clotting process and storage. 
Differentiation of the various deficien-
cies may be carried out by mixing various 
fractions with the plasma of the pro-
positus and noting the effect on the clot-
ting time of recalcified plasma. For ex-
ample, stored plasma will correct the 
clotting defect of PTC and PTA deficient 
plasmas but will not correct the clotting 
defect of AHG deficient plasma. 
LABORATORY FINDINGS 
Classically, Hemophilia is described as 
having a prolonged clotting time of whole 
blood. The other deficiencies also show 
a delay in clotting. The majority of cases 
with a clotting time of over 30 minutes 
and especially over 50 minutes have AHG 
deficiency. The majority of cases of PTC 
and PTA deficiencies have a clotting time 
of less than 30 minutes. Mild examples 
of these deficiencies may show a clotting 
time that is not prolonged. The pro-
thrombin consumption test of Quick 
which estimates the available thrombo-
plastic potency of the blood, shows that 
the prothrombin consumption is poor. 
Similar findings are found with PTC and 
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PTA deficiencies for this test. Here, too, 
very mild cases may present with an al-
most normal prothrombin consumption. 
Several other tests have been shown to 
be abnormal with classical hemophilia. 
They are listed below. 
1. Heparin clotting time is delayed. 
2. Dilution clotting times are pro-
longed . 
3. Recalcified plasma clotting time by 
either fast or slow centrifugation is 
increased. 
4. Bleeding time for deep cuts (5 mm. 
or greater) is increased. 
5. Thromboplastic activity test of Quick 
is positive. 
The Thomboplastin Generation Test is 
a very sensitive test for deficiencies of 
AHG, PTC, and PTA. The th ree condi-
tions may be distinguished readily by this 
test, as a rule. 
Factors in the blood which are found 
to be normal in value are as follows: 
1. Bleeding time of shallow cuts. 
2. Capillary fragility as shown by the 
tourniquet test. 
3. Clot retraction. 
4. Platelet count. 
5. Prothrombin level of plasma. 
6. Fibrinogen level of plasma. 
7. Calcium. 
8. Accelerator globulins. 
9. Serum Prothrombin Conversion 
Accelerator (SPCA). 
Tests for naturally occurring anti-
coagulants are negative. 
CLINI'CAL PICTURE 
The principal manifestation of these 
conditions is the presence of a bleeding 
tendency. The bleeding is usually of a 
slow persistant type lasting for days and 
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often initiated by trivial injuries. The 
bleeding tendency usually onsets early in 
life. Hemorrhage at circumcision is often 
the first sign. Later, bleeding or bruising 
after minor cuts, injuries, or tooth extrac-
tions may be excessive or even intractable. 
The manifestations and severity vary 
from patient to patient but are often re-
markably constant in any one person. 
Some live almost normal lives with little 
disability, while others, suffering from a 
severe form, die at an early age. It has 
also been shown that the degree of sever-
ity tends to be uniform throughout an 
affected family. 
AHG deficiency usually causes the most 
severe bleeding tendency, while PTA de-
ficiency usually has the least severe bleed-
ing. There often seems to be some rela-
tionship between the degree of clotting 
time increase and the severity of the 
hemorrhage. 
In AHG deficiency, it is commonly 
found that repeated hemorrhages into 
joints occurs with eventual production of 
arthritis, deformity, and limitation of 
movement due to formation of ankyloses. 
In this condition subcutaneous and intra-
muscular hemorrhages are frequent and 
often extensive and may be of a "spon-
taneous" nature. Hematuria may present 
in some people. Less commonly, asympto-
matic gastrointestinal bleeding is found. 
Hemorrhage in the Central Nervous Sys-
tem is rare. Purpura is uncommon. 
PTA deficiency seldom produces spon-
taneous bleeding. It is usually manifested 
after trauma, surgery, or commonly den-
tal extraction. Hemarthroses and purpura 
are rare. 
PTC deficiency lies in severity, between 
AHG and PTA deficiencies. Hemarth-
roses here are also uncommon. 
DIAGNOSIS 
The classical triad for the diagnosis of 
Hemophilia depended on three factors: 
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1. The characteristic type of bleeding 
beginning early in life. 
2. The heredofamilial sex-linked trans-
mission practically limited to males. 
3. Retarded coagulation reflected in 
elevated clotting times and poor 
prothrombin consumption. 
It can be seen that the above factors 
could not serve to differentiate AHG and 
PTC deficiencies. The most sensitive way 
of distinguishing these conditions involves 
the use of the Thromboplastin Generation 
Test. The final proof of the diagnosis of 
any of these deficiencies depends on the 
demonstration of the correction of the 




The activities of the child who has a 
tendency to bleed must be tempered as 
much as possible. In adults, the patient 
must learn to avoid strenuous exercises 
and active participation in vigorous sports. 




There should be an adequate intake of 
protein and Vitamin C. 
2. Pain-
Analgesics such as salicylates, codeine, 
or demerol should be used to control 
pain. 
3. Agents used to control hemorrhage-
(a) Whole Blood : 
Fresh whole blood is the method 
of choice in the treatment of 
AHG deficiency if the hematocrit 
is low. In Hemophilia, it has been 
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shown that an AHG level of 10-
20% of normal will assure ade-
quate clotting. Fresh whole blood 
transfusions provide a source of 
AHG which will cause a tempor-
ary decrease in the clotting time, 
lasting for several hours. It makes 
no difference in the clotting time 
if 100 cc. of blood is used or if 
500 cc. is used. Fresh frozen 
blood, reconstituted just before 
use, provides adequate AHG lev-
els. With severe bleeding, 100 
cc. of fresh citrated blood every 
6 to 8 hours may be given until 
the hemorrhage is controlled . 
With PTC and PTA deficiencies, 
stored blood should be used in 
preference since as stated above, 
the effect of these substances 
seems to be potentiated by clot-
ting and storage. 
(b) Plasma: 
With AHG deficiency, fresh 
whole plasma or reconstructed 
lyophylized fresh plasma should 
be used when the hematocrit is 
normal or high. If there is dan-
ger of serious hemorrhage, it may 
be necessary to provide a con-
tinuous supply of AHG by giving 
plasma every 3 or 4 hours or by 
a slow continuous IV drip. Once 
again, it is preferable to use 
stored plasma in the treatment of 
the patient who lacks either the 
PTC or PTA factors. 
(c) Globulin Substances: 
Plasma concentrates containing 
AHG such as Cohn fraction I 
may be given, but they are prob-
ably no better than simple trans-
fusions since the body cannot 
store AHG. Cohn fraction I is 
of no value in PTC deficiency 
and of questionable value in PTA 
deficiency. 
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(d) Local Hemostatics: 
For the treatment of bleeding ex-
ternal surfaces, bovine thrombin 
suspended in gelatin foam or 
freshly formed fibrin is the hemo-
static agent of choice. Powdered 
tannic acid or powdered Russell 
viper venom may be used, but 
they are not as satisfactory. 
4. Psychological Implications-
There must be a psychological readjust-
ment on the part of the patient with 
regard to the necessary restrictions of 
activity. The readjustment must also 
involve the mother of the patient be-
cause she may develop a guilt com-
plex knowing that she transmitted the 
disease to her child. 
5. Special Consideratio1ts-
7.2" 
( a) External bleeding: 
All the clot and other debris 
should be removed by gentle 
cleansing in order to get down 
to the oozing area. If necessary, 
the edges should be approximated, 
but without sutures. Bovine topi-
cal thrombin should then be ap-
plied promptly and liberally to 
the oozing area. A bandage 
should be applied to exert mod-
erate pr.essure. Bovine thrombin 
should be used in preference to 
human thrombin because of the 
possibility of developing serum 
hepatitis. 
(b) Hemarthroses: 
These should be treated conserva-
tively. At first cold is applied di-
rectly to the joint which should 
· subsequently be kept at rest. Con-
currently, active treatment should 
be undertaken to control the clot-
ting defect. Later, heat may be 
cautiously applied to absorb the 
extravasated blood. Some people 
advocate aspirating the joint at 
this stage with installation of 
hyaluronidase into the joint cavi-
ty. A course of light massage, 
passive exercise, and then grad-
ual activated exercises should be 
instituted to keep ankyloses at a 
minimum. 
(c) Carious teeth: 
These are also best treated con-
servatively. They should be filled 
in preference to extraction and no 
local anesthetic should be used. 
Teeth should only be extracted 
for intractable pain. If extraction 
is to be performed, the patient 
should be brought into hospital. 
A gutta percha or wax mold of 
the mouth and gums !.hould be 
made in order to produce pressure 
around the tooth to be extracted. 
After the extraction, the socket 
should be dusted prophylactically 
with powdered thrombin and then 
the mold placed. Transfusions 
may be considered . 
(d) Surgery: 
Surgery should be avoided as 
much as possible. Septic condi-
tions should be treated with anti-
biotics preferably, and cancer by 
irradiation. If surgery is abso-
lutely necessary, the patient should 
be transfused before the operation 
with the proper substances in 
order to control the clotting de-
fect. The transfusions should be 
carried on at intervals until the 
wound heals. 
(e) Refractoriness to blood and 
plasma: 
Here, cortisone and ACTH may 
temporarily diminish the refrac-
toriness of the patient to blood 
and plasma. Transfusions with 
heparinized plasma may help also. 
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Summary 
AHG, PTC, and PTA deficiencies have 
been discussed from the aspects of patho-
logical physiology, differentiation of the 
various components, genetics, laboratory, 
investigation, clinical picture, diagnoses, 
and modern concepts of treatment. 
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The disease may be latent (the patient 
being asymptomatic), mild, or severe, in 
which case there is anemia, jaundice, and 
exacerbations of acute crises. The basic 
defect is the spherical shape of the red 
blood cells which invites destruction by 
the spleen, resulting in accelerated bile 
pigment metabolism, hyperplastic bone 
marrow, reticulocytosis, and anemia. 
The spherocyte anomaly is an inherited 
Mendelian dominant characteristic, trans-
mitted by either parent. A diagnosis 
should be made only when spherocytes 
can be demonstrated in the patient, and 
a parent, sibling, or offspring. Persistence 
of spherocytosis and increased osmotic 
and mechanical fragility are also essen-
tial characteristics. 
The spleen is responsible for the rapid 
elimination of spherocytes. Splenectomy 
relieves the manifestations of the disease 
although the basic defect remains. The 
success of this operation depends upon 
the removal of all splenic tissue. 
Excessive bilirubin excretion leads to 
the formation of gallstones in 75% of 
cases. Bilirubinemia is seen without bili-
rubinuria. Hemoglobinemia and hemo-
globinuria are not seen in uncomplicated 
hereditary spherocytosis. 
The pathogenesis of the crises in this 
disease is unknown, but is probably re-
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lated to increased hemolysis, transient 
marrow aplasia, and splenic effects on 
the marrow. 
The management of the crises as ad-
vised by some is multiple transfusions and 
early splenectomy; others urge caution in 
the use of transfusions because of severe 
reactions. Some defer both transfusion 
and splenectomy in hopes of a remission. 
-Robert J. Tuttle, '56 
ERYTHROBLASTOSIS FETALIS 
Neva M. Abelson 
Post graduate Medicine 
Vol. 18, No. 4, October 1955 
Two etiologic agents manifest as two 
equally common forms of hemolytic dis-
ease of the newborn. 
( 1) ABO Erythroblastosis: 
One fourth of all babies possess ery-
throcytes that are incompatible with the 
mother's serum, but the baby which de-
velops hemolytic disease has group A 
cells while the mother must have group 
0 cells. The disease usually is mild, but 
if the serum bilirubin approaches 20 
mgm%, exchange transfusion with fresh 
group 0 cells is indicated. 
(2) Rh Erytbroblastosis: 
One in seventeen Rh negative females 
become sensitized during pregnancy. 
Hemolytic disease may ensue. 
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Treatment 
(1) Prophylaxis: 
Every Rh negative female should have 
three Rh antibody tests during pregnancy; 
at 16 weeks (base line), 30 weeks and 
35 weeks. Rising titer suggests hemolytic 
disease. 
In the event of intra-uterine death three 
potential dangers confront the mother: 
(a) emotional shock, (b) hypo-protei-
nemia as the result of rapid polyhydram-
nios and (c) disturbances of coagulation 
with possible serious hemorrhage. 
Clinical Cases 
A thirty-eight year old white, married, 
housewife with three children was re-
ferred to Victoria Hospital, London, for 
treatment of leukemia. The patient indi-
cated that she had not felt well for the 
preceding .six months, during which time 
her .conjunctivae and skin became yellow 
and pallor was superimposed as well. The 
urine had been perhaps a bit darker but 
the stools had remained normal in color. 
At age 16, this · patient had begun to 
have bouts of jaundice which were pain-
less. Eventually pain in the right upper 
quadrant supervened and led to an oper-
ation on the gall bladder, at age 34. 
Following this, jaundice continued to 
occur sporadically but was painless. The 
patient's father and brother gave his-
tories or many bouts of painless jaundice. 
On examination, there was fairly marked 
pallor and mild icterus. There were no 
fundal changes, no palpably enlarged 
lymph nodes and no bone tenderness. 
The spleen tip was palpable 9.0 em. be-
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(2) Definitive: 
(a) interruption of pregnancy at the 
37th or 38th week, if the husband is 
homozygous, there is a history of incom-
patible blood transfusion and the anti Rh 
titer is greater than 1:64. Exchange trans-
fusion prevents kernicterus in the baby. 
(b) normal delivery and immediate ex-
change transfusion with packed group 
0 cells. This with re-exchange trans-
fusion controls fetal blood volume and 
anemia. 
The criteria for exchange transfusion 
is to seek justification for withholding it. 
-Bill Hogg, '57 
W. P. Barton, M.D., F.R.C.P. (C) 
low the left costal margin in the mid-
clavicular line on quiet breathing. 
Laborato.ry Examination 
Hemoglobin-9.0 Gm. (N 12 · 16 Gm.) 
White count-14,500 (N 5 - 10,000) 
Reticulocytes-12.5% (N 0.5 · 1.0%) . 
Examination of smear of peripheral 
blood: 
normal diff,.rential 
many small dense red cells with no 
area of central pallor: many large 
cells 
platelets numerous. . . 




This disease is comm·only called familial 
alcholuric jaundice, which is less accur-
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ate than the term hereditary spherocytosis 
because some .of these patients do not have 
jaundice and have only the mildest 
anemia. The diagnosis can be suspected 
by history and confirmed usually by 
simply looking at a well-prepared smear 
of peripheral blood. 
Splenectomy is curative. The red cell 
abnormality persists but the red cell sur-
vival time returns to the normal range 
once the spleen is removed. If this pro-
cedure is carried out at a sufficiently 
early age, it is likely that cholelithiasis 
might be circumvented. 
Twelve-year-old girl was admitted to 
hospital because of a generalized purpuric 
eruption, ready bruising and epistaxes of 
one week's duration. 
Three weeks previous to admission the 
patient and two siblings, as well as other 
children at 3chool, had had measles. 
On examination there were no ab-
normal findings except for the numerous 
petechiae and bruises, which had no pre-
dilection for any particular area. The 
spleen was not palpable. 
Laboratory Examination 
Hemoglobin - 13.0 Gm. (N 12.0 -
14.0 Gm.) 
W.B.C. - 8,500 (N 5 - 10,000) 
Platelets - 26,000 (N 300,000). 
Examination of smear of peripheral blood: 
differential - normal 
red cells - normal 
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platelets - rare. 
Capillary fragility test - 3+ 
Bleeding time 20 min. 
Examination of bone marrow: 
Many megakaryocytes, few of which 
were forming platelets. No abnormal 
cells seen. Erythroid and granulocyte 
series normal. 
Diagnosis 
Acute Thrombocytopenic Purpura (post-
infectious measles). 
Comment 
Acute thrombocytopenic purpura is al-
most always a self-limited disease, which 
requires no therapy unless active bleed-
ing is in progress. Even then, splenec-
tomy is not advisable. 
This child made a quite uneventful re-
covery and, at the end of three weeks, 
had a normal platelet count. 
A twenty-eight year old white married 
female was first seen at Victoria Hospital, 
London, because of excessive uterine 
bleeding, epistaxes and prolonged bleed-
ing after a tooth extraction at age 26. 
At that time her platelet count was found 
to be in the range 50,000 - 80,000. In 
the two years following her first admis-
sion she had bruised readily, but had not 
had any alarming blood loss. Consist-
ently during that time, her platelet count 
remained subnormal. The bone marrow 
was normal. The spleen was not palpable. 
It was decided that definitive therapy 
should be undertaken. 
Accordingly, after pre-operative prepar-
ation with cortisone and transfusion with 
blood from siliconized apparatus, splenec-
tomy was performed. 
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The spleen was of normal size and 
microscopically showed no lesions. The 
platelet count was normal within several 
days and has remained so for a period 
of 9 months. 
Diagnosis 
Chronic idiopathic thrombocytopenia. 
Comment 
Chronic idiopathic thrombocytopenia is 
a different disease from the acute form. 
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By definition, spontaneous cure is rare. 
Splenectomy offers a 70-80% chance of 
cure. Why 20-30% fail to benefit from 
the operation is not known, nor can one 
predict in advance which patients will 
respond. 
As a rule, cortisone or related adrenal 
steroids will elevate the platelet count in 
these patients while it is being adminis-
tered, but the count reverts to low levels 
on discontinuing the drug. A splenec-
tomy seems to be a much more definite 
measure and is without any of the un-
pleasant side effects of prolonged steroid 
therapy. 
77 
List of Recent Accessions 
December 1, 1955 to February 1, 1956 
The Library of the Medical School contains about 50,000 volumes, all fully 
catalogued, and is re~:arded as one of the best working collections of its kind in 
Canada. It is particularly rich in complete files of the more important medical 
journals. The books are on open shelves and students have access to all books and 
current journals. 
ANIMAL CULTURE 
Asdell, S. A.: Cattle fertility and ster-
ility. 1955. 
BACfERIOLOGY 
Burnet, F. M. : Principles of animal 
virology. 1955. 
BOTANY 
Ainsworth, G. C.: A dictionary of the 
fungi. 1954. 
DENTISTRY 
Johnson, A. L.: Dentistry as I see it 
today. 1955. 
GYNECOLOGY AND OBSTETRICS 
Bowes, K.: Modern trends in obstetrics 
and gynecology. 1955. 
Brocq, P.: Atlas d'hysterographie. 1953. 
Holland, E. L. : British obstetric and 
gynecological practice. 1955. 
HUMAN ANATOMY 
Belt, E.: Leonardo the anatomist. 1955. 
Brock, R. C.: The anatomy of the bron-
chial tree. 1954. 
INTERNAL MEDICINE 
Arieti, S.: Interpretation of schizo-
phrenia. 1955. 
78 
Bicknell, F.: The vitamins in medicine. 
1953. 
Hamburger, F. : The medical care of 
the aged and chronically ill. 1955. 
Hunter, D .: The diseases of occupa-
tions. 1955. 
International Neurochemical Sympos-
ium. Biochemistry of the develop· 
ing nervous system. 1954. 
McGill University: Prospect and retro-
spect in neurology. 1955. 
Medlar, E. M.: The behavior of pul· 
monary tuberculous lesions. 1954. 
Oliven, J. F., Sexual hygiene and path-
ology. 1955. 
Werner, S. C.: The thyroid. 1955. 
Williamson, P.: Office procedures. 
1955. 
MEDICAL BIBLIOGRAPHY 
Gacrison, F. H.: Gacrison and Morton's 
Medical bibliography. 1954. 
U.S. Library of Congress: Scientific and 
technical serial publication, United 
States, 1950-1953. 1954. 
MEDICINE (GENERAL) 
American Foundation: Medical re-
search: a midcentury survey. 1955. 
Guthrie, D.: From witchcraft to anti· 
sepsis. 1955. 
U.W.Q. MEDICAL jOURNAL 
Taylor, S. J . L. : Good general prac-
tice. 19:>4. 
NATURAL HISTORY 
Arber, A.: The mind and the eye. 1954. 
Oster, G .: Physical techniques in bio-
logical research. v. 1, 1955. 
PEDIATRICS 
American Academy of Pediatrics. For 
the welfare of children. 1955. 
PHYSIOLOGY 
Veith, 1. : Perspectives m physiology. 
1954. 
Wynder, E. L. : The biologic effects of 
tobacco. 1955 . 
PUBLIC ASPECTS OF MEDICINE 
Cope, Z .: The history of St. Mary's 
hospital medical school. 1954. 
SECOND WORLD WAR-MEDICAL 
SERVICES 
Hachiya, M .: Hiroshima diary. 1955. 
Jeffcott, G. F.: United States Army 
Dental Service in World War II. 
1955. 
MARCH, 1956 
Rexford-Welch, S. C. : The Royal Air 
Force medical services. v. 1, Admin-
istration. 1954. 
SURGERY 
Bickham, W. S. : Surgery of the ali-
mentary tract. 1955 . 
Borgognoni, T .: The surgery of Theo-
doric, ca. A.D. 1267. 1955. 
Cole, W . H .: Operative technic in gen-
eral surgery. 1955 . 
Henry Ford Hospital : International 
symposium on cardiovascular surgery. 
1955. 
THERAPEUTICS 
American Medical Association: Glan-
dular physiology and therapy. 1954. 
Hardy, J. D.: Fluid therapy. 1954. 
Klaunberg, H . J. : Tea : a symposium 
on the pharmacology and the physio-
logic effects of tea. 1955. 
ZOOLOGY 
Conference on Group Processes. 1st, 
1954. 
79 
UNIVERSITY OF WESTERN ONTARIO MEDICAL JOURNAL 
LAC-MAC LTD. 
425 RECTORY STREET 
LONDON, CANADA 
The Exclusive Source of EyeresJ 
Green 0. R. Items 
Also Manufacturers of : 
Office and Lab Coats, Cotton 
Trousers, Tunics, 0. R. Suits .. . 
A Complete Line of Hospital 
Garments and Textile Products. 
UNIVERSITY OF WESTERN ONTARIO 
LONDON CANADA 
The University, founded in 1878, has been co-educational since its 
inception. Jt has two Faculties-Medicine and Arts and Science. There 
are five affi li ated coll eges. Four of them give a complete four-year course 
leading to an Arts degree. One (Alma) is a Junior College offering the 
first two years' work only. One offers music (Music Teachers' College) 
and one is theological only (Huron). 
The postwar urge for higher education has materially increased the 
total registration of the University in the las t decade. 
For particulars regarding admission requirements, courses of study, 
fees, scholarships, etc., write THE REGISTRAR. 
When writing advertisers please mention University of \Xfestern Ontario Medical Journal 
